1995 …2024
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2016 2024

Research Output 1995 2019

DNA-repair gene mutations are highly prevalent in circulating tumour dna from multiple myeloma patients

Mithraprabhu, S., Hocking, J., Ramachandran, M., Choi, K., Klarica, D., Khong, T., Reynolds, J. & Spencer, A., 29 Jun 2019, In : Cancers. 11, 7, 14 p., 917.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
3 Citations (Scopus)

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Mithraprabhu, S., Morley, R., Khong, T., Kalff, A., Bergin, K., Hocking, J., Savvidou, I., Bowen, K. M., Ramachandran, M., Choi, K., Wong, B. K. L., Reynolds, J. & Spencer, A., Aug 2019, In : Leukemia. 33, 8, p. 2022-2033 12 p.

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)

Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study)

Kalff, A., Khong, T., Mithraprabhu, S., Bergin, K., Reynolds, J., Bowen, K. M., Thakurta, A., Guzman, R., Wang, M., Couto, S., Ren, Y. & Spencer, A., Jun 2019, (Accepted/In press) In : Leukemia and Lymphoma. 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Panobinostat (LBH589) in combination with the β-catenin inhibitor Tegavivint (BC2059) exerts significant anti-myeloma activity both in vitro and in vivo

Spencer, A., Savvidou, I., Khong, T. & Mithraprabhu, S., 12 Sep 2019, (Accepted/In press) p. 214-214. 1 p.

Research output: Contribution to conferencePosterOtherpeer-review

4 Citations (Scopus)
Open Access

Prizes

Platform Access Grant (PAG)

Karen Maria Alt (Recipient), Tiffany Tee Fern Khong (Recipient) & Ioanna Savvidou (Recipient), Jun 2016

Prize: Prize (including medals and awards)